Back

Proteomic analysis of extracellular vesicles released from endothelial cells in vitro reveals increased levels of E-selectin and dual specificity phosphatase 7 as a potential marker of TNFα-mediated apoptosis

Collier, M. E. W.; Cao, T. H.; Quinn, P. A.; Sandhu, J. K.; Jones, D. J. L.; Goodall, A. H.

2026-02-02 cell biology
10.64898/2026.01.30.702474 bioRxiv
Show abstract

Proteins can be actively packaged into extracellular vesicles (EVs) through mechanisms dependent on the stimulus that activated the cells. Identifying proteins released in endothelial EVs in response to stimuli relevant to cardiovascular disease (CVD) may therefore reveal potential biomarkers that provide information about the vascular endothelium. This study aimed to identify differentially expressed proteins in EVs released from human umbilical vein endothelial cells (HUVEC) in response to stimuli relevant to vascular endothelium activation. HUVEC were stimulated with TNF (10 ng/mL) or oxLDL (10 {micro}g/mL). Apoptosis was assessed using a flow cytometric DNA fragmentation protocol and caspase-3/7 activity assay. Size distributions of EVs were examined by nanoparticle tracking analysis. Isolated EVs were examined using tandem liquid-chromatography-mass spectrometry (LC-MS/MS). While treatment of HUVECs with TNF or oxLDL resulted in non-significant elevations in levels of EVs, only TNF increased apoptosis. Mass spectrometry quantified 1355 proteins and revealed significant differences in the proteome of EVs from TNF-treated HUVEC compared to EVs from oxLDL-treated or untreated cells. Several candidate biomarkers were significantly and differentially expressed in response to TNF, including E-selectin and dual specificity phosphatase 7. This study further associated E-selectin on endothelial-derived EVs with endothelial apoptosis and may offer a biomarker of endothelial damage in patients with CVD.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
International Journal of Molecular Sciences
453 papers in training set
Top 0.2%
9.4%
2
Journal of the American Heart Association
119 papers in training set
Top 0.8%
8.7%
3
PLOS ONE
4510 papers in training set
Top 24%
7.0%
4
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.1%
5.0%
5
Scientific Reports
3102 papers in training set
Top 30%
4.1%
6
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 0.6%
3.7%
7
Cells
232 papers in training set
Top 0.8%
3.2%
8
Frontiers in Immunology
586 papers in training set
Top 2%
3.2%
9
PROTEOMICS
35 papers in training set
Top 0.2%
3.0%
10
Journal of Extracellular Vesicles
50 papers in training set
Top 0.1%
3.0%
50% of probability mass above
11
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
2.8%
12
The FASEB Journal
175 papers in training set
Top 0.6%
2.1%
13
Atherosclerosis
29 papers in training set
Top 0.6%
1.9%
14
Physiological Reports
35 papers in training set
Top 0.5%
1.7%
15
Biology
43 papers in training set
Top 1%
1.3%
16
Neurobiology of Disease
134 papers in training set
Top 3%
1.3%
17
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 2%
0.9%
18
Journal of Proteome Research
215 papers in training set
Top 2%
0.9%
19
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
20
Pharmaceuticals
33 papers in training set
Top 1%
0.8%
21
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.8%
22
American Journal of Physiology-Heart and Circulatory Physiology
32 papers in training set
Top 1%
0.8%
23
Frontiers in Molecular Biosciences
100 papers in training set
Top 5%
0.8%
24
Cellular and Molecular Bioengineering
21 papers in training set
Top 0.3%
0.8%
25
Fluids and Barriers of the CNS
21 papers in training set
Top 0.3%
0.8%
26
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
27
Journal of Cerebral Blood Flow & Metabolism
43 papers in training set
Top 0.7%
0.7%
28
Biomaterials
78 papers in training set
Top 1%
0.7%
29
EBioMedicine
39 papers in training set
Top 1%
0.7%
30
Life Sciences
25 papers in training set
Top 2%
0.7%